Fasciola hepatica-Derived Proteins Shield the Heart From Type 2 Myocardial Infarction in Rats by Modulating Oxidative

Mohammadreza Ahmadi-Beni1, Kobra Mokhtarian2,3, Gholam Reza Mobini2

  • 1Student Research Committee, Shahrekord University of Medical Sciences, Shahrekord, Iran, skums.ac.ir.

Insights

Fasciola hepatica extract protected against type 2 myocardial infarction (T2MI) by reducing inflammation and oxidative stress. This helminth therapy shows promise for treating ischemic heart disease and supports the hygiene hypothesis.

Area of Science:

  • Cardiology
  • Immunology
  • Parasitology

Background:

  • Type 2 myocardial infarction (T2MI) has a worse prognosis than type 1 MI.
  • The hygiene hypothesis links reduced microbial exposure to immune dysregulation and inflammation.
  • Helminth therapy's impact on oxidative stress in myocardial injury is not well understood.

Purpose of the Study:

  • To investigate if Fasciola hepatica total protein extract (FhTE) attenuates T2MI via immune modulation.
  • To assess FhTE's effects on inflammation and oxidative stress in T2MI.
  • To explore FhTE's potential as a novel therapy for ischemic heart disease.

Main Methods:

  • Male Wistar rats were pretreated with FhTE daily for 6 days.
  • Myocardial infarction was induced using isoproterenol.
  • Evaluated electrocardiographic changes, cardiac hypertrophy, serum markers, antioxidant enzyme activities, oxidative stress markers, inflammatory markers, and gene expression.

Main Results:

  • FhTE pretreatment attenuated MI-induced electrocardiographic changes, cardiac hypertrophy, and serum cardiac injury markers.
  • FhTE enhanced antioxidant defense (increased SOD, CAT; decreased NO, MDA) and modulated Nrf2.
  • FhTE reduced inflammatory cell activity (MPO, iNOS) and downregulated pro-inflammatory cytokines (IL-1β, IL-6, TNF-α, IL-33).

Conclusions:

  • FhTE exhibits significant cardioprotective effects against T2MI by modulating inflammation and oxidative stress.
  • FhTE preconditioning offers a potential therapeutic strategy for T2MI.
  • Findings support the hygiene hypothesis in ischemic heart disease, suggesting helminth therapy as a novel treatment avenue.